The blockage of the IFN-α/β receptor with monoclonal antibodies prevents diabetes in nonobese diabetic mice (10, 11), and the inhibition of IFN-α-mediated intracellular signaling in a model of β-cells prevents the overexpression of MHC I (12). This evidence concerns the gene IFNA1 and diabetes mellitus.